505 related articles for article (PubMed ID: 11507221)
1. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
[TBL] [Abstract][Full Text] [Related]
2. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters.
Groves AK; Cotter MA; Subramanian C; Robertson ES
J Virol; 2001 Oct; 75(19):9446-57. PubMed ID: 11533207
[TBL] [Abstract][Full Text] [Related]
3. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
Tso FY; West JT; Wood C
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
[TBL] [Abstract][Full Text] [Related]
5. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
Verma SC; Lan K; Choudhuri T; Robertson ES
J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
[TBL] [Abstract][Full Text] [Related]
7. A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences.
Watanabe A; Higuchi M; Fukushi M; Ohsawa T; Takahashi M; Oie M; Fujii M
Virus Genes; 2007 Apr; 34(2):127-36. PubMed ID: 17143723
[TBL] [Abstract][Full Text] [Related]
8. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Garber AC; Shu MA; Hu J; Renne R
J Virol; 2001 Sep; 75(17):7882-92. PubMed ID: 11483733
[TBL] [Abstract][Full Text] [Related]
9. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
Sun Z; Jha HC; Robertson ES
J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
11. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells.
Hu J; Garber AC; Renne R
J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.
Purushothaman P; McDowell ME; McGuinness J; Salas R; Rumjahn SM; Verma SC
J Virol; 2012 Sep; 86(18):9983-94. PubMed ID: 22761383
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Renne R; Barry C; Dittmer D; Compitello N; Brown PO; Ganem D
J Virol; 2001 Jan; 75(1):458-68. PubMed ID: 11119614
[TBL] [Abstract][Full Text] [Related]
14. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma associated herpes virus-encoded viral FLICE inhibitory protein activates transcription from HIV-1 Long Terminal Repeat via the classical NF-kappaB pathway and functionally cooperates with Tat.
Sun Q; Matta H; Chaudhary PM
Retrovirology; 2005 Feb; 2():9. PubMed ID: 15713234
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance.
Juillard F; De León Vázquez E; Tan M; Li S; Kaye KM
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626680
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
18. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
[TBL] [Abstract][Full Text] [Related]
19. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.
Verma SC; Choudhuri T; Kaul R; Robertson ES
J Virol; 2006 Mar; 80(5):2243-56. PubMed ID: 16474132
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
